In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Isis, Lilly revise cancer drug agreement
Lilly initiates clinical trials on second cancer drug discovered in Isis collaboration
Isis Pharmaceuticals Announces Extension of Antisense Cancer Drug Discovery Collaboration With Lilly
Isis achieves milestone drug discovery collaboration
Pittsburgh Forms Alliance with Eli Lilly
Eli Lilly Extends Cooperation with Optimata, Developer of Virtual Patient Technology
Lilly and Isis announce strategic alliance